{
  "resourceType" : "ActivityDefinition",
  "id" : "AntithromboticProphylaxisFondaparinuxSubcutaneous",
  "meta" : {
    "profile" : ["https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/drug-administration-action"]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ActivityDefinition AntithromboticProphylaxisFondaparinuxSubcutaneous</b></p><a name=\"AntithromboticProphylaxisFondaparinuxSubcutaneous\"> </a><a name=\"hcAntithromboticProphylaxisFondaparinuxSubcutaneous\"> </a><a name=\"AntithromboticProphylaxisFondaparinuxSubcutaneous-en-US\"> </a><p><b>url</b>: <a href=\"ActivityDefinition-AntithromboticProphylaxisFondaparinuxSubcutaneous.html\">ActivityDefinition Antithrombotic prophylaxis with Fondaparinux</a></p><p><b>version</b>: 0.1</p><p><b>name</b>: ProphylacticFondaparinuxApplicationActivity</p><p><b>title</b>: Antithrombotic prophylaxis with Fondaparinux</p><p><b>status</b>: Active</p><p><b>experimental</b>: true</p><p><b>subject</b>: <span title=\"Codes:{http://hl7.org/fhir/fhir-types Patient}\">Patient</span></p><p><b>date</b>: 2024-08-07 14:55:39+0000</p><p><b>publisher</b>: NUM CODEX+ CELIDA</p><p><b>description</b>: </p><div><p>Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients (when contraindications for LWMH exist)</p>\n</div><p><b>kind</b>: MedicationRequest</p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>product</b>: <span title=\"Codes:{http://snomed.info/sct 708189008}, {http://fhir.de/CodeSystem/bfarm/atc B01AX05}\">Fondaparinux (substance)</span></p><blockquote><p><b>dosage</b></p></blockquote></div>"
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
    "valueCode" : "computable"
  },
  {
    "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel",
    "valueCode" : "structured"
  }],
  "url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/antithrombotic-prophylaxis-fondaparinux-administration",
  "version" : "0.1",
  "name" : "ProphylacticFondaparinuxApplicationActivity",
  "title" : "Antithrombotic prophylaxis with Fondaparinux",
  "status" : "active",
  "experimental" : true,
  "subjectCodeableConcept" : {
    "coding" : [{
      "system" : "http://hl7.org/fhir/fhir-types",
      "code" : "Patient"
    }]
  },
  "date" : "2024-08-07T14:55:39+00:00",
  "publisher" : "NUM CODEX+ CELIDA",
  "description" : "Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients (when contraindications for LWMH exist)",
  "kind" : "MedicationRequest",
  "code" : {
    "coding" : [{
      "system" : "http://snomed.info/sct",
      "code" : "432102000",
      "display" : "Administration of substance (procedure)"
    }]
  },
  "productCodeableConcept" : {
    "coding" : [{
      "system" : "http://snomed.info/sct",
      "code" : "708189008",
      "display" : "Fondaparinux (substance)"
    },
    {
      "system" : "http://fhir.de/CodeSystem/bfarm/atc",
      "code" : "B01AX05",
      "display" : "Fondaparinux"
    }]
  },
  "dosage" : [{
    "timing" : {
      "repeat" : {
        "frequency" : 1,
        "period" : 1,
        "periodUnit" : "d"
      }
    },
    "route" : {
      "coding" : [{
        "system" : "http://snomed.info/sct",
        "code" : "34206005",
        "display" : "Subcutaneous route (qualifier value)"
      }]
    },
    "doseAndRate" : [{
      "doseQuantity" : {
        "value" : 2.5,
        "unit" : "mg",
        "system" : "http://unitsofmeasure.org",
        "code" : "mg"
      }
    }]
  }]
}